|
|
|
Volumn 147, Issue 51-52, 2005, Pages 34-
|
|
Diabetes in treatment with antipsychotic drugs: who is at risk;Diabetes unter Antipsychotika: Wer ist gefährdet.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
ADULT;
ARTICLE;
CASE CONTROL STUDY;
CHEMICALLY INDUCED DISORDER;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PSYCHOSIS;
RISK FACTOR;
ADULT;
ANTIPSYCHOTIC AGENTS;
CASE-CONTROL STUDIES;
CLOZAPINE;
DIABETES MELLITUS, TYPE 2;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
PSYCHOTIC DISORDERS;
RISK FACTORS;
|
|
EID: 33644852589
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
